1. Manjra A I ,Moosa A, Bhamjee A., Fatal neonatal meningitis and ventriculitis caused by multiresistant Achromobacter Xylosoxidans. A case report. South African Medical Journal 1989;76:571-573

2. Manjra A I, Ireland P, House Dust Mite avoidance strategies Part II : Current Allergy 1990; 3 :13-15

3. Manjra A I : Chronic Sinusitis And Allergy in Children . Current Allergy . 1991; 4:10-13

4. South African Childhood Asthma Working Group(SACAWG) : Management of Acute Asthmatic Attacks in Children. South African Medical Journal :1993;83:286-89

5. Manjra A I :Editorial . Current Allergy 1993;6:2

6. SACAWG : Theophylline in Childhood and Adolescent Asthma. SAMJ 1993;1:2913-14

7. Manjra A I : Monitoring and Modifying the environment of Mite Sensitive allergic patients. CME 1994;12:64-70.

8. Manjra A I ,Berman D , Weinberg E G, Gous E, Potter P C : Comparison between the Acarex test and a Der p1 ELISA for the detection of house dust mites in the homes of asthmatic sufferers. SAMJ. 1994;84: 220-22

9. Manjra A I, Berman D, Toerien A, Weinberg E G, Potter P C. The effect of a single treatment of an acaricide , Acarosan and a detergent Metsan , on Der p1 allergen levels in the carpets and mattresses of asthmatic children . SAMJ 1994; 84:278-80.

10. Manjra A I . Home nebulizers and spacers . South African Family Practice. 1994 15: 565-568.

11. Manjra A I . Anaphylaxis . Specialist Medicine. 1994;16:17-24.

12. SACAWG : Clinical Guidelines :Management of Childhood and Adolescent asthma.1994 Consensus. SAMJ 1994; 84: 862-866.

13. Jooma O F, Weinberg E G, Berman D, Manjra A. I , Potter P C : Accumulation of house dust mite (Der p1) levels on mattress covers. SAMJ 1995;85:1002-1005

14. Manjra A I : Editorial . Current Allergy and Clinical Immunology. 1995; 8:2

15. Manjra A I , Prescott R , Potter P C : Cockroach Allergy in Durban .Current Allergy and Immunology 1995;8: 3-7.

16. .Potter P C, Davis G, Manjra A I , Luyt D: House dust mite allergy in Southern Africa-historical perspective and current status. Clinical and Experimental Allergy . 1996; 26:132-137.

17. .South African Allergic Rhinitis Working Group. Allergic rhinitis in South Africa-diagnosis and management. SAMJ 1996; 86:1315-1328.

18. Manjra A I : Approaches to difficult problems in allergy . Specialist Medicine 1996;18:30.

19. Manjra A.I.: Perspective on long acting beta 2 agonist. Mims Prescribing Power. 1996;1: 62-67

20. Manjra AI New Approaches in managing household allergens in South Africa. Continuing Medical Education Journal 1997;15: 693-699.

21. Manjra A. I. Urticaria. The Journal of Modern Pharmacy 1999;6:33-35

22. Ferguson A C , Spier S, Manjra A I, Versteegh FGA, Mark S, Zhang P. Efficay and safety of high-dose inhaled steroids in children with asthma : A comparison of fluticasone propionate with budesonide. Journal of Paediatrics 1999; 134:422-427

23. Manjra A. I. Gaps in the management of asthma. Current Allergy and Immunology 1999;12:2-3

24. Manjra A I. Editorial. Current Allergy and Immunology . 1999;12:12-14

25. Motala C, Kling S, Gie R, Potter PC, Manjra AI, Vermeulen, Weinberg EG, Green R. Guidelines for the management of chronic asthma in children –2000 update. South African Medical Journal 2000; 90: 524-53

26. Children with otitis media and tonsilitis in routine medical practice in South Africa. The efficacy and Safety of Cefpodoxime Proxetil. South African Medical Journal 2000; 90:1-8.

27. Manjra A. I. House Dust Mites and Cockroach Sensitivity in South Africa. Current Allergy and Clinical Immunology 2000;13:24-26.

28. Manjra A I et al. Effect of nebulised fluticasone propionate 1mg twice daily compared with oral prednisone in children aged 4—16 years with an acute exacerbation of asthma. Respiratory Medicine. 2000; 94:1206-1214.

29. Manjra A I . Combination therapy in asthma. Continuing Medical Education Journal 2002; 20:160-162

30. Wahn. U, Bos. J D, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul Carle, Molloy S, Graber M, Thurston M, de Prost Y. Efficacy and safety of Pimecrolimus cream in the lomg term management of atopic dermatitis in children. Pediatrics 2002,110(1pt 1):e2

31. Scicchtitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni L, Boulet p, Naya I P , Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Current Medical Research and Opinion 2004: 20 (9) :1403-1418.

32. Chuchalin A G, Manjra A I , Rozinova NN< Skopkova O, Cioppa G D, Till D, Kaiser G, Fashiola T, Kottakis D. Formoterol delivered via a new multi-dose powder Iinhaler ( Certihaler) is as effective and well tolerated as the Formoterol Dry powder inhaler ( Aerolizer) in chldren with persistent asthma. Journal of Aerosol Medicine 2005, 18 (1) 63-73

33. Manjra A I , Du Plessis P, Weiss R, Motala C, Potter PC, Raboobee et al Childhood atopic eczema consensus document document. SAMJ 2005,95 (6) :435-40

34. Lopata Al, Groenewald M, Manjra AI, Du Toit, Sibanda EN et al Sensitization to three cockroach species in Southern Africa. Current allergy and clinical immunology 2005; 18: 62-66

35. Manjra A I . Food Allergy :Feeding the allergic infant . South African Paediatric review. 2005; 2: 34-9

36. Potter PC, Manjra A I, Weiss R, et al. Problematic Childhood Atopic eczema consensus Document. S Afr Med J 2006. 96:86-7.

37. Pedersen S , Gacia Garcia ML, manjra A, Theron I, Engelstatter R. A comparative study of inhaled ciclesonide 160ug/day and fluticasone propionate 176ug/day in children with asthma . Pediatr Pulmonol. 2006 Oct;41(10):954-61

38. Potter PC, Carter G, Davis G, Desmarais P, Freidman R, Gill M, Gravet C, Green R, Groenewald M, Hockman, Jeena P, Jooma O, Joyce G, Manjra A, Ossip M, Seedat R, Vidjak D, Wolff L. Clinical management of allergic rhinitis-The Allergy Society of South Africa Consensus Update. S Afr med J. 2006Dec;96 (12 pt2):1269-72

39. Manjra A I. Use and abuse of steroids in upper airway allergic disorders. Current Allergy and Clinical Immunology 2006 Nov;19(4):187-90.

40. Kuna P, Peters MJ, Manjra A I, Jorup C, naya IP, Martinez-Jimenez NE, Buhl R. Effect of budesonie/formoterol maintenance and reliever therapy on asthma exacerbations.Int J Clin Prac.2007may;61(5):725-36.

41. Chylack LT, Gross GN, Pedinoff A, Ciclesonide Lenticular Safety Study Group : A randomized controlled trial to investigate the effect of ciclosonide and beclometasone dipropionate on eye lens opacity. J Asthma 2008 Dec:45(10):893-902.

42. Manjra A I, Nel H, Maharaj B: Effect of desloratadine on patients with allergic rhinitis and exercise induced bronchoconstriction : a placebo controlled study. J Asthma 2009 Mar(2):156-9.

43. Motala C, Green R, Manjra AI, Potter PC, Zar HJ. Guidelines for the management of asthma in children-2009 update. S Afr med J 2009 Dec 8:99(12):897-912.

44. Green RJ, Hockman M, Friedman R, Vardas E, Cole P, Halkas A, Feldman C; Allergic rhinitis in South Africa: 2012 guidelines. South African Allergic Rhinitis Working Group (SAARWG). S Afr Med J. 2012 Jun 7;102(8):693-6.

45. Levin ME, Gray CL, Goddard E, Karabus S, Kriel M, Lang AC, Manjra AI, Risenga SM, Terblanche AJ, van der Spuy DA; South African food allergy consensus document. South African Food Allergy Working Group.S Afr Med J. 2015 Jan;105(1):62-5.

46. A J Terblanche, A C Lang, C L Gray, E Goddard, S Karabus, M Kriel, A I Manjra, S M Risenga, D A van der Spuy, M E Levin. Non-IgE-mediated food allergies. for the South African Food Allergy Working Group (SAFAWG). S Afr Med J 2015;105(1):66

47. A C Lang, A I Manjra, A J Terblanche, S M Risenga, C L Gray, E Goddard, S Karabus, M Kriel, D A van der Spuy, M E Levin. Exclusion diets and challenges in the diagnosis of food allergy for the South African Food Allergy Working Group (SAFAWG). S Afr Med J 2015;105(1):67-68.

48. C L Gray, E Goddard, S Karabus, M Kriel, A C Lang, A I Manjra, S M Risenga, A J Terblanche, D A van der Spuy, M E Levin. Epidemiology of IgE-mediated food allergy for the South African Food Allergy Working Group (SAFAWG). S Afr Med J 2015;105(1):68-69.

49. D A van der Spuy, A J Terblanche, S Karabus, M Kriel, A I Manjra, E Goddard, C L Gray, A C Lang, S M Risenga, M E Levin. Diagnosis of food allergy: History, examination and in vivo and in vitro tests: S Afr Med J 2015;105(1):69-70.

50. A C Lang, D A van der Spuy, E Goddard, A J Terblanche, M Kriel, C L Gray, S Karabus, A I Manjra, S M Risenga, M E Levin. Elimination diets and dietary interventions for the management of food allergies for the South African Food Allergy Working Group (SAFAWG). S Afr Med J 2015;105(1):72-73.

51. S M Risenga, M Kriel, S Karabus, A I Manjra, C L Gray, E Goddard, A C Lang, A J Terblanche, D A van der Spuy, M E Levin. Severe food allergy and anaphylaxis: Treatment, risk assessment and risk reduction for the South African Food Allergy Working Group (SAFAWG). S Afr Med J 2015;105(1):71-72.

52. S Karabus, C L Gray, E Goddard, M Kriel, A C Lang, A I Manjra, S M Risenga, A J Terblanche, D A van der Spuy, M E Levin, Vaccination in food allergic patients for the South African Food Allergy Working Group (SAFAWG). S Afr Med J 2015;105(1):73.

53. C L Gray, E Goddard, S Karabus, M Kriel, A C Lang, A I Manjra, S M Risenga, A J Terblanche, D A van der Spuy, M E Levin. Novel therapies in the management of food allergy: Oral immunotherapy and anti-IgE for the South African Food Allergy Working Group (SAFAWG). S Afr Med J 2015;105(1)74.

54. R Masekela,C L Gray; R J Green,; A I Manjra ; F E Kritzinger, M Levin,; H Zar,; The increasing burden of asthma in South African children: A call to action on behalf of the South African Childhood Asthma Working Group S Afr Med J 2018;108(7):537-539.

55. R Masekela, S M Risenga, O P Kitchin,D A White, G Davis, P Goussard, ; A I Manjra,; F EKritzinger,; M Levin,; H Zar, R J Green. The diagnosis of asthma in children: An evidence based approach to a common clinical dilemma on behalf of the South African Childhood Asthma Working Group (SACAWG) S Afr Med J 2018;108(7):540-545.

56. R Masekela, A Jeevanathrum, S Kling, C LGray, J Morrison, A Vanker, A S Puterman, D Rhode,; E W Zöllner,; P de Waal, A I Manjra, M Levin, ; H Zar,; R J Green; F EKritzinger,; Asthma treatment in children: A pragmatic approach on behalf of the South African Childhood Asthma Working Group (SACAWG) S Afr Med J 2018;108(8):612-618.

57. R Masekela,; M Levin, P M Jeena, M Annamalai,; V Naidoo,; A van Niekerk, ; D Hawarden,; S Emanuel,; H Katz,; H Zar,; R J Green,; F E Kritzinger,A I Manjra,, M; Looking beyond the magic bullet: Novel asthma drugs or education, which works better? on behalf of the South African Childhood Asthma Working Group (SACAWG) S Afr Med J 2018;108(8):619-623.

58. Manjra A I. Cutaneous Manifestations of Mastocytosis. Current Allergy and Clinical Immunology. 2019;32 (3):134-139.

59. Manjra A I. ALLSA Congress . Current Allergy and Clinical Immunology. 2020;33(2),61

60.  Susanna Kannenberg, Sarah Karabus, Willem Visser, Jamilabibi Aboobaker, Magdalena Kriel, Michael Levin, Basil Magigaba, Ahmed Manjra, Rupesh Misra, Pholile Mpofu, Azwitamisi Tshigabe, Thomas Luger Paediatric atopic eczema (atopic dermatitis) in South Africa: a practical algorithm for the management of mild-to-moderate disease in daily clinical practice.2020 In Press.